Petr Marusic
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Petr Marusic.
Seizure-european Journal of Epilepsy | 2009
Robert Kuba; Milan Brázdil; Miroslav Kalina; Tomáš Procházka; Jiří Hovorka; Tomáš Nežádal; Jan Hadač; Klára Brožová; Věra Sebroňová; Vladimír Komárek; Petr Marusic; Hana Ošlejšková; Jana Zárubová; Ivan Rektor
We performed a retrospective, multicenter, open-label study to evaluate the efficacy of vagus nerve stimulation (VNS) in all patients in the Czech Republic who have received this treatment for at least 5 years (n=90). The mean last follow-up was 6.6+/-1.1 years (79+/-13 months). The median number of seizures among all patients decreased from 41.2 seizures/month in the prestimulation period to 14.9 seizures/month at 5 years follow-up visit. The mean percentage of seizure reduction was 55.9%. The responder rate in these patients is in concordance with the decrease of overall seizure frequency. At 1 year after beginning the stimulation, 44.4% of patients were responders; this percentage increased to 58.7% after 2 years. At the 5 years last follow-up 64.4% of patients were responders, 15.5% experienced > or = 90% seizure reduction, and 5.5% were seizure-free. A separate analysis of patients younger than 16 years of age showed lower efficacy rates of VNS in comparison to the whole group. Complications and chronic adverse effects occurred in 13.3% of patients. VNS is an effective and safe method to refractory epilepsy in common clinical practice.
Epilepsia | 2013
Sándor Beniczky; H. Aurlien; Jan Brogger; A. Fuglsang-Frederiksen; António Martins-da-Silva; Eugen Trinka; Gerhard H. Visser; Guido Rubboli; Helle Hjalgrim; Hermann Stefan; Ingmar Rosén; Jana Zárubová; Judith Dobesberger; Jørgen Alving; Kjeld Andersen; Martin Fabricius; M.D. Atkins; Miri Y. Neufeld; Perrine Plouin; Petr Marusic; Ronit Pressler; Ruta Mameniskiene; Rüdiger Hopfengärtner; Walter van Emde Boas; Peter Wolf
The electroencephalography (EEG) signal has a high complexity, and the process of extracting clinically relevant features is achieved by visual analysis of the recordings. The interobserver agreement in EEG interpretation is only moderate. This is partly due to the method of reporting the findings in free‐text format. The purpose of our endeavor was to create a computer‐based system for EEG assessment and reporting, where the physicians would construct the reports by choosing from predefined elements for each relevant EEG feature, as well as the clinical phenomena (for video‐EEG recordings). A working group of EEG experts took part in consensus workshops in Dianalund, Denmark, in 2010 and 2011. The faculty was approved by the Commission on European Affairs of the International League Against Epilepsy (ILAE). The working group produced a consensus proposal that went through a pan‐European review process, organized by the European Chapter of the International Federation of Clinical Neurophysiology. The Standardised Computer‐based Organised Reporting of EEG (SCORE) software was constructed based on the terms and features of the consensus statement and it was tested in the clinical practice. The main elements of SCORE are the following: personal data of the patient, referral data, recording conditions, modulators, background activity, drowsiness and sleep, interictal findings, “episodes” (clinical or subclinical events), physiologic patterns, patterns of uncertain significance, artifacts, polygraphic channels, and diagnostic significance. The following specific aspects of the neonatal EEGs are scored: alertness, temporal organization, and spatial organization. For each EEG finding, relevant features are scored using predefined terms. Definitions are provided for all EEG terms and features. SCORE can potentially improve the quality of EEG assessment and reporting; it will help incorporate the results of computer‐assisted analysis into the report, it will make possible the build‐up of a multinational database, and it will help in training young neurophysiologists.
Epilepsia | 2011
Ruta Mameniskiene; Thomas Bast; Carla Bentes; Maria Paola Canevini; Petia Dimova; Tiziana Granata; Hans Høgenhaven; Bosanka Jocic Jakubi; Petr Marusic; Gayane Melikyan; Roberto Michelucci; Konstantin Mukhin; Bernhard Oehl; Francesca Ragona; Andrea O. Rossetti; Guido Rubboli; Susanne Schubert; Ulrich Stephani; Julia Strobel; Aglaia Vignoli; Jana Zárubová; Peter Wolf
Purpose: To gain new insights into the clinical presentation, causes, treatment and prognosis of epilepsia partialis continua (EPC), and to develop hypotheses to be tested in a prospective investigation.
Epileptic Disorders | 2013
Martin Kudr; Pavel Krsek; Petr Marusic; Martin Tomášek; Jiri Trnka; Katerina Michalova; Monika Jaruskova; Jan Sanda; Martin Kyncl; Josef Zamecnik; Jan Rybar; Alena Jahodova; Milan Mohapl; Vladimír Komárek; Michal Tichy
AimsTo assess the practical localising value of subtraction ictal single-photon emission computed tomography (SISCOM) coregistered with MRI and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with extratemporal epilepsy and normal MRI.MethodsWe retrospectively studied a group of 14 patients who received surgery due to intractable epilepsy and who were shown to have focal cortical dysplasia, undetected by MRI, based on histological investigation. We coregistered preoperative SISCOM and PET images with postoperative MRI and visually determined whether the SISCOM focus, PET hypometabolic area, and cerebral cortex, exhibiting prominent abnormalities on intracranial EEG, were removed completely, incompletely, or not at all. These results and histopathological findings were compared with postoperative seizure outcome.ResultsTwo patients underwent one-stage multimodal imageguided surgery and the remaining 12 underwent long-term invasive EEG. SISCOM findings were localised for all but 1 patient. FDG-PET was normal in 3 subjects, 2 of whom had favourable postsurgical outcome (Engel class I and II). Complete resection of the SISCOM focus (n=3), the area of PET hypometabolism (n=2), or the cortical regions with intracranial EEG abnormalities (n=7) were predictive of favourable postsurgical outcome. Favourable outcome was also encountered in: 4 of 8 patients with incomplete resection and 1 of 2 with no resection of the SISCOM focus; 4 of 7 patients with incomplete resection and 1 of 2 with no resection of the PET hypometabolic area; and 2 of 7 patients with incomplete resection of the area corresponding to intracranial EEG abnormality. Nocorrelation between histopathological FCD subtype and seizure outcome was observed.ConclusionComplete resection of the dysplastic cortex localised by SISCOM, FDG-PET or intracranial EEG is a reliable predictor of favourable postoperative seizure outcome in patients with non-lesional extratemporal epilepsy.
Epilepsia | 2016
Brian E. Mouthaan; Matea Rados; Péter Barsi; Paul Boon; David W. Carmichael; Evelien Carrette; Dana Craiu; J. Helen Cross; Beate Diehl; Petia Dimova; Dániel Fabó; Stefano Francione; Vladislav Gaskin; Antonio Gil-Nagel; Elena Grigoreva; Alla Guekht; Edouard Hirsch; Hrvoje Hećimović; Christoph Helmstaedter; Julien Jung; Reetta Kälviäinen; Anna Kelemen; Vasilios K. Kimiskidis; Teia Kobulashvili; Pavel Krsek; Giorgi Kuchukhidze; Pål G. Larsson; Markus Leitinger; Morten I. Lossius; Roman Luzin
In 2014 the European Union–funded E‐PILEPSY project was launched to improve awareness of, and accessibility to, epilepsy surgery across Europe. We aimed to investigate the current use of neuroimaging, electromagnetic source localization, and imaging postprocessing procedures in participating centers.
Seizure-european Journal of Epilepsy | 2016
Teia Kobulashvili; Julia Höfler; Judith Dobesberger; Florian Ernst; Philippe Ryvlin; J. Helen Cross; Kees P. J. Braun; Petia Dimova; Stefano Francione; Hrvoje Hećimović; Christophe Helmstaedter; Vasilios K. Kimiskidis; Morten I. Lossius; Kristina Malmgren; Petr Marusic; Bernhard J. Steinhoff; Paul Boon; Dana Craiu; Norman Delanty; Dániel Fabó; Antonio Gil-Nagel; Alla Guekht; Edouard Hirsch; Reetta Kälviäinen; Ruta Mameniskiene; Cigdem Ozkara; Margitta Seeck; Guido Rubboli; Pavel Krsek; Sylvain Rheims
PURPOSE The European Union-funded E-PILEPSY network aims to improve awareness of, and accessibility to, epilepsy surgery across Europe. In this study we assessed current clinical practices in epilepsy monitoring units (EMUs) in the participating centers. METHOD A 60-item web-based survey was distributed to 25 centers (27 EMUs) of the E-PILEPSY network across 22 European countries. The questionnaire was designed to evaluate the characteristics of EMUs, including organizational aspects, admission, and observation of patients, procedures performed, safety issues, cost, and reimbursement. RESULTS Complete responses were received from all (100%) EMUs surveyed. Continuous observation of patients was performed in 22 (81%) EMUs during regular working hours, and in 17 EMUs (63%) outside of regular working hours. Fifteen (56%) EMUs requested a signed informed consent before admission. All EMUs performed tapering/withdrawal of antiepileptic drugs, 14 (52%) prior to admission to an EMU. Specific protocols on antiepileptic drugs (AED) tapering were available in four (15%) EMUs. Standardized Operating Procedures (SOP) for the treatment of seizure clusters and status epilepticus were available in 16 (59%). Safety measures implemented by EMUs were: alarm seizure buttons in 21 (78%), restricted patients ambulation in 19 (70%), guard rails in 16 (59%), and specially designated bathrooms in 7 (26%). Average costs for one inpatient day in EMU ranged between 100 and 2200 Euros. CONCLUSION This study shows a considerable diversity in the organization and practice patterns across European epilepsy monitoring units. The collected data may contribute to the development and implementation of evidence-based recommended practices in LTM services across Europe.
Epilepsy & Behavior | 2013
Amos D. Korczyn; Steven C. Schachter; Martin J. Brodie; Sarang S. Dalal; Jerome Engel; Alla Guekht; Hrvoje Hećimović; Karim Jerbi; Andres M. Kanner; Cecilie Johannessen Landmark; Pavel Mareš; Petr Marusic; Stefano Meletti; Marco Mula; Philip N. Patsalos; Markus Reuber; Philippe Ryvlin; Klára Štillová; Roberto Tuchman; Ivan Rektor
Epilepsy is, of course, not one disease but rather a huge number of disorders that can present with seizures. In common, they all reflect brain dysfunction. Moreover, they can affect the mind and, of course, behavior. While animals too may suffer from epilepsy, as far as we know, the electrical discharges are less likely to affect the mind and behavior, which is not surprising. While the epileptic seizures themselves are episodic, the mental and behavioral changes continue, in many cases, interictally. The episodic mental and behavioral manifestations are more dramatic, while the interictal ones are easier to study with anatomical and functional studies. The following extended summaries complement those presented in Part 1.
European Journal of Neuroscience | 2012
Josef Zamecnik; Aleš Homola; Michal Cicanic; Klara Kuncova; Petr Marusic; Pavel Krsek; Eva Syková; Lydia Vargova
Focal cortical dysplasias (FCDs) of the brain are recognized as a frequent cause of intractable epilepsy. To contribute to the current understanding of the mechanisms of epileptogenesis in FCD, our study provides evidence that not only cellular alterations and synaptic transmission, but also changed diffusion properties of the extracellular space (ECS), induced by modified extracellular matrix (ECM) composition and astrogliosis, might be involved in the generation or spread of seizures in FCD. The composition of the ECM in FCD and non‐malformed cortex (in 163 samples from 62 patients) was analyzed immunohistochemically and correlated with the corresponding ECS diffusion parameter values determined with the real‐time iontophoretic method in freshly resected cortex (i.e. the ECS volume fraction and the geometrical factor tortuosity, describing the hindrances to diffusion in the ECS). The ECS in FCD was shown to differ from that in non‐malformed cortex, mainly by the increased accumulation of certain ECM molecules (tenascin R, tenascin C, and versican) or by their reduced expression (brevican), and by the presence of an increased number of astrocytic processes. The consequent increase of ECS diffusion barriers observed in both FCD type I and II (and, at the same time, the enlargement of the ECS volume in FCD type II) may alter the diffusion of neuroactive substances through the ECS, which mediates one of the important modes of intercellular communication in the brain – extrasynaptic volume transmission. Thus, the changed ECM composition and altered ECS diffusion properties might represent additional factors contributing to epileptogenicity in FCD.
Epilepsy Research | 2010
Filip Barinka; Rastislav Druga; Petr Marusic; Pavel Krsek; Josef Zamecnik
Focal cortical dysplasias (FCDs) represent a prominent cause of pharmacologically intractable epilepsy. In FCD, the decrease of parvalbumin immunoreactive (PV+) inhibitory interneurons has been repeatedly documented. Here, we wanted to show whether another interneuronal population, the calretinin immunoreactive (CR+) neurons, exhibits any change in human FCD. We also investigated samples of morphologically normal temporal neocortex resected together with sclerotic hippocampus (nHSTN), where decrease of PV+ interneurons was previously documented as well. Brain tissue from 24 patients surgically treated for pharmacoresistant epilepsy was examined. Calretinin immunoreactivity was qualitatively evaluated and the density of CR+ neuronal profiles was quantified. As a control, post-mortem acquired neocortical samples of nine patients without any brain affecting disease were used. CR+ neurons were located predominantly in superficial cortical layers both in controls and pathological samples. Similarly, the morphology of CR+ neurons was unaffected in pathological samples. The overall density of CR+ neurons was significantly decreased in FCD type I (to approximately 70% of control values) and even more in FCD type II (to approximately 50% of controls). In nHSTN, no change compared to controls was found in CR+ neuronal density. Our results may contribute to the better understanding of the role of individual interneuronal populations in epileptogenesis.
Epileptic Disorders | 2007
Petr Marusic; Martin Tomášek; Pavel Krsek; Hana Krijtová; Jana Zárubová; Josef Zamecnik; Milan Mohapl; Vladimír Beneš; Michal Tichý; Vladimír Komárek
BACKGROUND Mesial temporal lobe epilepsy (MTLE) with hippocampal sclerosis (HS) constitutes a distinct clinical syndrome with variable pathogenesis. Extrahippocampal regions may be affected in MTLE/HS, association with cortical dysplasia is common and temporal polar cortex is frequently involved in seizure onset. Patients with dual pathology may have favourable outcome from the surgery provided that both pathologies are removed. The aim of the study was to review clinical variables of MTLE/HS patients in order to distinguish preoperatively patients with associated microscopic cortical dysplasia in the temporal pole. METHODS A series of 38 patients with the clinical diagnosis of MTLE and histopathologically proven HS were analysed. Patients were divided into two groups on the basis of histopathological finding in the temporal polar cortex: HS associated with malformation of cortical development (group HS+, n = 19) and a group with isolated HS (group HS, n = 19). Demographic, clinical, electrographic and seizure semiology variables were obtained and their prevalence compared between both groups. RESULTS At least one insult was identified in early childhood history of 18 patients in the HS group in comparison to 10 patients in the HS+ group (p < 0.01). Complicated febrile seizures were found in both groups with similar prevalence, the history of early childhood CNS infection prevailed in the HS group (p < 0.01). Absence of aura was reported in HS group only. Patients in the the HS+ group had earlier surgery (p < 0.05) but the seizure outcome was comparable between groups. CONCLUSIONS Microscopic dual pathology is common in MTLE/HS patients. This group of patients is difficult to distinguish preoperatively on the basis of noninvasive electrographic features or ictal clinical semiology. Detailed information regarding the possible precipitating insult in the history may be of critical importance.